Publications 2013 – 2004

Web

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).
Ann Oncol. 2013 Aug;24(8):2062-7. doi: 10.1093/annonc/mdt165. Epub 2013 May 10.
stetoscopio
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
Clin Colorectal Cancer. 2012 Mar;11(1):71-6. doi: 10.1016/j.clcc.2011.06.013. Epub 2011 Sep 8.
stetoscopio
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study.
Ann Oncol. 2011 Mar;22(3):712-7. doi: 10.1093/annonc/mdq412. Epub 2010 Sep 1.
stetoscopio
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial.
Lancet Oncol. 2010 Sep;11(9):845-52. doi: 10.1016/S1470-2045(10)70175-3. Epub 2010 Aug 9.
stetoscopio
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Ann Oncol. 2008 Feb;19(2):299-307. Epub 2007 Oct 17.
stetoscopio
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
J Clin Oncol. 2007 May 1;25(13):1670-6.
stetoscopio
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
Cancer. 2004 Aug 15;101(4):704-12.

Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
Gynecol Oncol. 2004 May;93(2):474-8.

stetoscopio
stetoscopio